{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:46:19Z","timestamp":1782269179400,"version":"3.54.5"},"reference-count":102,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARM"],"abstract":"<jats:p>Mucopolysaccharidosis (MPS) are a group of inherited lysosomal storage genetic disorders that affect the body\u2019s ability to break down glycosaminoglycans (GAGs) due to the deficiency of required enzymes. This leads to depositions of these GAGs in various tissues and organs resulting in multi-systemic manifestations including pulmonary and sleep related issues. In recent years, there have been significant advancements in therapeutic options and supportive management which have led to the overall improvement in respiratory care, culminating in improved quality of life for MPS patients. Management of pulmonary and sleep disorders in mucopolysaccharidosis requires a multidisciplinary approach due to the multi-systemic affectation of the genetic disorders. Therapeutic options such as enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT) have yielded varying success in mitigating respiratory complications. Emerging treatments such as gene therapies have shown exciting and promising results thus far. Supportive therapies such as airway clearance, regular vaccination and use of positive airway pressure devices are also essential. Pre-operative airway and anesthesia planning is critical to mitigate peri-operative and post-operative complications. Early diagnosis, close monitoring and a patient focused individualized approach are essential for respiratory optimization and overall improvement in clinical outcomes. This review article aims to discuss these advancements in a comprehensive format, making it accessible to medical providers who care for this subset of patients.<\/jats:p>","DOI":"10.3390\/arm94030041","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:03:23Z","timestamp":1782263003000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review"],"prefix":"10.3390","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4176-8271","authenticated-orcid":false,"given":"Bimaje","family":"Akpa","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kubaski, F., de Oliveira Poswar, F., Michelin-Tirelli, K., Matte, U.D.S., Horovitz, D.D., Barth, A.L., Baldo, G., Vairo, F., and Giugliani, R. (2020). Mucopolysaccharidosis Type I. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030161"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2174\/138920111795542714","article-title":"Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical picture and treatment","volume":"12","author":"Beck","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1399-6576.1987.tb02553.x","article-title":"Mucopolysaccharidoses and anaesthetic risks","volume":"31","author":"Pedersen","year":"1987","journal-title":"Acta Anaesthesiol. Scand."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-0455.2002.430108.x","article-title":"Airway changes in children with mucopolysaccharidoses","volume":"43","author":"Shih","year":"2002","journal-title":"Acta Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/ajmg.a.33902","article-title":"Sleep abnormalities in untreated patients with mucopolysaccharidosis type VI","volume":"155A","author":"John","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prrv.2010.10.005","article-title":"Respiratory manifestations in mucopolysaccharidoses","volume":"12","author":"Muhlebach","year":"2011","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-016-0425-z","article-title":"Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis","volume":"11","author":"Rutten","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gadepalli, C., Stepien, K.M., Sharma, R., Jovanovic, A., Tol, G., and Bentley, A. (2021). Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score. J. Clin. Med., 10.","DOI":"10.3390\/jcm10153275"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.7150\/ijms.61827","article-title":"Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses","volume":"18","author":"Lee","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, Y.H., Su, C.H., Lin, C.Y., Lin, H.Y., Lin, S.P., Chuang, C.K., and Lee, K.S. (2023). Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA. J. Pers. Med., 13.","DOI":"10.3390\/jpm13030494"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e71007","DOI":"10.1002\/ppul.71007","article-title":"Tracheobronchial Involvement of Mucopolysaccharidosis Type VI","volume":"60","author":"Ufuk","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2013.10.015","article-title":"Increased incidence of neonatal respiratory distress in infants with mucopolysaccharidosis type II (MPS II, Hunter syndrome)","volume":"111","author":"Dodsworth","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2017.08.008","article-title":"Pathophysiology, evaluation, and management of sleep disorders in the mucopolysaccharidoses","volume":"122S","author":"Rapoport","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_15","first-page":"e79773","article-title":"Polysomnographic Analysis of Sleep-Disordered Breathing In Children With Mucopolysaccharidoses in Qatar: A Retrospective Study","volume":"17","author":"Asir","year":"2025","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"Berger","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jpeds.2012.11.039","article-title":"Relationship of sleep to pulmonary function in mucopolysaccharidosis II","volume":"162","author":"Wooten","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-015-0255-4","article-title":"Sleep disordered breathing in mucopolysaccharidosis I: A multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome","volume":"10","author":"Pal","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11325-013-0862-z","article-title":"Home sleep study characteristics in patients with mucopolysaccharidosis","volume":"18","author":"Kasapkara","year":"2014","journal-title":"Sleep Breath."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/ajmg.a.62229","article-title":"Evaluation of sleep-disordered breathing and its relationship with respiratory parameters in children with mucopolysaccharidosis Type IVA and VI","volume":"185","author":"Emiralioglu","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJM195908202610804","article-title":"Pulmonary disability in the Hurler syndrome (lipochondrodystrophy): A study of two cases","volume":"261","author":"Murray","year":"1959","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejim.2016.05.017","article-title":"Unique medical issues in adult patients with mucopolysaccharidoses","volume":"34","author":"Mitchell","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S0104-42302010000300009","article-title":"Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: Recommendations from a group of Brazilian F experts","volume":"56","author":"Giugliani","year":"2010","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jimd.12079","article-title":"Enzyme replacement therapy outcomes across the disease spectrum: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program","volume":"42","author":"Harmatz","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_26","first-page":"258","article-title":"Mucopolysaccharidosis type VI: Clinical aspects, diagnosis and treatment with enzyme replacement therapy","volume":"112","author":"Politei","year":"2014","journal-title":"Arch. Argent. Pediatr."},{"key":"ref_27","first-page":"CD009806","article-title":"Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI","volume":"3","author":"Brunelli","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"Wraith","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2408402","DOI":"10.1155\/2020\/2408402","article-title":"Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive\/Palliative Therapies","volume":"2020","author":"Nan","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_30","first-page":"143","article-title":"Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome","volume":"16","author":"Lee","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"ref_31","first-page":"65","article-title":"Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients","volume":"3","author":"Parini","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2013.02.014","article-title":"Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI","volume":"109","author":"Horovitz","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13023-014-0129-1","article-title":"Clinical efficacy of enzyme replacement therapy in paediatric Hunter patients, an independent study of 3.5 years","volume":"9","author":"Tomanin","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2020.07.004","article-title":"The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I","volume":"132","author":"Broomfield","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_35","first-page":"507","article-title":"Respiratory muscular strength in children with mucopolysacaridosis: Comparison with predictive equations","volume":"76","author":"Reinaux","year":"2024","journal-title":"Minerva Pediatr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0025-7125(16)31190-7","article-title":"Respiratory muscle failure","volume":"67","author":"Rochester","year":"1983","journal-title":"Med. Clin. N. Am."},{"key":"ref_37","first-page":"39","article-title":"Evaluation of disease severity in mucopolysaccharidoses","volume":"3","author":"Beck","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymgme.2022.08.007","article-title":"Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa","volume":"137","author":"Mitchell","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10545-016-9973-6","article-title":"Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome","volume":"39","author":"Hendriksz","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"ref_41","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). GeneReviews, University of Washington."},{"key":"ref_42","first-page":"311","article-title":"Review of the use of idursulfase in the treatment of mucopolysaccharidosis II","volume":"2","author":"Burrow","year":"2008","journal-title":"Biologics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jpeds.2004.03.002","article-title":"Treatment of respiratory system (not just lung!) abnormalities in Mucopolysaccharidosis I","volume":"144","author":"Allen","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/ajmg.a.38459","article-title":"Genotypic-phenotypic features and enzyme replacement therapy outcome in patients with mucopolysaccharidosis VI from Turkey","volume":"173","author":"Dursun","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109135","DOI":"10.1016\/j.ymgme.2025.109135","article-title":"Long-term enzyme replacement therapy: Findings from the mucopolysaccharidosis VI clinical surveillance program after 15 years follow-up","volume":"145","author":"Burton","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10545-014-9686-7","article-title":"Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: An international case series","volume":"37","author":"Lampe","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_50","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: A review","volume":"2012","author":"Tomatsu","year":"2012","journal-title":"Res. Rep. Endocr. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: Efficacy and limitations","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s10038-019-0662-9","article-title":"Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future","volume":"64","author":"Chen","year":"2019","journal-title":"J. Hum. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2012.07.002","article-title":"Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model","volume":"107","author":"Rowan","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A Phase 2\/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymgme.2015.12.157","article-title":"Implementing evidence-driven individualized treatment plans within Morquio A Syndrome","volume":"117","author":"Clarke","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9592.2012.03897.x","article-title":"Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: The impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management","volume":"22","author":"Kirkpatrick","year":"2012","journal-title":"Pediatr. Anesth."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10545-016-0006-2","article-title":"Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: The 30-year University of Minnesota experience","volume":"40","author":"Rodgers","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_58","first-page":"81","article-title":"Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series","volume":"41","author":"Selvanathan","year":"2018","journal-title":"JIMD Rep."},{"key":"ref_59","first-page":"675","article-title":"[Treatment of 2 children with mucopolysaccharidosis by allogeneic hematopoietic stem cell transplantation]","volume":"25","author":"Chen","year":"2008","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/bloodadvances.2022007212","article-title":"Hematopoietic stem cell transplant for Hurler syndrome: Does using bone marrow or umbilical cord blood make a difference?","volume":"6","author":"Orchard","year":"2022","journal-title":"Blood Adv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1183\/09059180.00008012","article-title":"Respiratory manifestations in patients with inherited metabolic diseases","volume":"22","author":"Santamaria","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1460-9592.2012.03825.x","article-title":"A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses","volume":"22","author":"Frawley","year":"2012","journal-title":"Pediatr. Anesth."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"Hematopoietic cell transplantation for inherited metabolic diseases: An overview of outcomes and practice guidelines","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10545-012-9563-1","article-title":"Anaesthesia and airway management in mucopolysaccharidosis","volume":"36","author":"Walker","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","article-title":"Hematopoietic stem cell transplantation for Morquio A syndrome","volume":"117","author":"Yabe","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1460-9592.2012.03904.x","article-title":"Anesthetic care and perioperative complications of children with Morquio syndrome","volume":"22","author":"Theroux","year":"2012","journal-title":"Pediatr. Anesth."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"437\u2013452; quiz 453-4","DOI":"10.1586\/ehm.11.39","article-title":"Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up","volume":"4","author":"Bhatia","year":"2011","journal-title":"Expert Rev. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1586\/17474086.2013.816507","article-title":"Fertility issues following hematopoietic stem cell transplantation","volume":"6","author":"Tichelli","year":"2013","journal-title":"Expert Rev. Hematol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Tulebayeva, A., Sharipova, M., and Boranbayeva, R. (2020). Respiratory Dysfunction in Children and Adolescents with Mucopolysaccharidosis Types I, II, IVA, and VI. Diagnostics, 10.","DOI":"10.3390\/diagnostics10020063"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hampe, C.S., Wesley, J., Lund, T.C., Orchard, P.J., Polgreen, L.E., Eisengart, J.B., McLoon, L.K., Cureoglu, S., Schachern, P., and McIvor, R.S. (2021). Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. Biomolecules, 11.","DOI":"10.3390\/biom11020189"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Hampe, C.S., Eisengart, J.B., Lund, T.C., Orchard, P.J., Swietlicka, M., Wesley, J., and McIvor, R.S. (2020). Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology. Cells, 9.","DOI":"10.3390\/cells9081838"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_75","first-page":"103","article-title":"Combined Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation in Mucopolysacharidosis Type VI","volume":"2","author":"Sillence","year":"2012","journal-title":"JIMD Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/GIM.0b013e3181f6e74d","article-title":"Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey","volume":"12","author":"Mendelsohn","year":"2010","journal-title":"Genet. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijporl.2014.11.014","article-title":"Adenoids of patients with mucopolysaccharidoses demonstrate typical alterations","volume":"79","author":"Keilmann","year":"2015","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ijporl.2014.03.021","article-title":"Mucopolysaccharidosis: Otolaryngologic findings, obstructive sleep apnea and accumulation of glucosaminoglycans in lymphatic tissue of the upper airway","volume":"78","author":"Sivri","year":"2014","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"112167","DOI":"10.1016\/j.ijporl.2024.112167","article-title":"Tracheostomy in children with mucopolysaccharidosis: A systematic review","volume":"187","author":"Galluzzi","year":"2024","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13052-018-0555-0","article-title":"ENT and mucopolysaccharidoses","volume":"44","author":"Bianchi","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01799267","article-title":"Mucopolysaccharidosis type IVA (Morquio syndrome): A clinical review","volume":"19","author":"Northover","year":"1996","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.athoracsur.2016.02.113","article-title":"Surgical Reconstruction for Severe Tracheal Obstruction in Morquio A Syndrome","volume":"102","author":"Pizarro","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/EJA.0000000000001109","article-title":"Anaesthesia and orphan disease: Tracheal reconstruction in two children with Morquio disease","volume":"37","author":"Hack","year":"2020","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_85","first-page":"100487","article-title":"The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis","volume":"20","author":"Kenth","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijporl.2016.02.015","article-title":"Tracheobronchial stents in mucopolysaccharidosis","volume":"83","author":"Karl","year":"2016","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lao, H.C., Lin, Y.C., Liang, M.L., Yang, Y.W., Huang, Y.H., Chan, Y.L., Hsu, Y.W., Lin, S.P., Chuang, C.K., and Cheng, J.K. (2022). The Anesthetic Strategy for Patients with Mucopolysaccharidoses: A Retrospective Cohort Study. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081343"},{"key":"ref_88","first-page":"e27474","article-title":"Anaesthetic Management in Mucopolysaccharidoses Patients: Clinical Experience in a Tertiary Hospital","volume":"14","author":"Machado","year":"2022","journal-title":"Cureus"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0022-3468(93)90240-L","article-title":"Children with mucopolysaccharidosis: Perioperative care, morbidity, mortality, and new findings","volume":"28","author":"Belani","year":"1993","journal-title":"J. Pediatr. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13052-018-0554-1","article-title":"Anesthesiological risks in mucopolysaccharidoses","volume":"44","author":"Moretto","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5664\/jcsm.11340","article-title":"A novel three-dimensional-printed customized nasal mask for improving CPAP adherence and satisfaction for the treatment of obstructive sleep apnea","volume":"21","author":"Tong","year":"2025","journal-title":"J. Clin. Sleep Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1034\/j.1399-0004.2002.620512.x","article-title":"Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): A survey of managing clinicians","volume":"62","author":"Fraser","year":"2002","journal-title":"Clin. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/adc.2004.065482","article-title":"Sleep disturbance in Sanfilippo syndrome: A parental questionnaire study","volume":"90","author":"Fraser","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-079X.2005.00294.x","article-title":"Impairment of the melatonin rhythm in children with Sanfilippo syndrome","volume":"40","author":"Guerrero","year":"2006","journal-title":"J. Pineal Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2017.09.010","article-title":"Practical management of behavioral problems in mucopolysaccharidoses disorders","volume":"122S","author":"Escolar","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Stepien, K.M., Bentley, A., Chen, C., Dhemech, M.W., Gee, E., Orton, P., Pringle, C., Rajan, J., Saxena, A., and Tol, G. (2022). Non-cardiac Manifestations in Adult Patients with Mucopolysaccharidosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.839391"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jped.2022.12.001","article-title":"Vaccination strategies for people living with inborn errors of metabolism in Brazil","volume":"99","author":"Ramos","year":"2023","journal-title":"J. Pediatr. (Rio. J.)"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13023-022-02402-w","article-title":"Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: A scoping review","volume":"17","author":"Gnasso","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1399-0004.1988.tb03423.x","article-title":"Clinical findings in 12 patients with MPS IV A (Morquio\u2019s disease). Further evidence for heterogeneity. Part III: Odontoid dysplasia","volume":"33","author":"Nelson","year":"1988","journal-title":"Clin. Genet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00586-022-07168-0","article-title":"Spinal cord compression in patients with mucopolysaccharidosis","volume":"31","author":"Pantel","year":"2022","journal-title":"Eur. Spine J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13023-019-1080-y","article-title":"Recommendations for the management of MPS VI: Systematic evidence- and consensus-based guidance","volume":"14","author":"Akyol","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_102","first-page":"100769","article-title":"Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries","volume":"28","author":"Solano","year":"2021","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["Advances in Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2543-6031\/94\/3\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:47:09Z","timestamp":1782265629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2543-6031\/94\/3\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":102,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["arm94030041"],"URL":"https:\/\/doi.org\/10.3390\/arm94030041","relation":{},"ISSN":["2543-6031"],"issn-type":[{"value":"2543-6031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}